Technology
New On Robinhood
Health
TransMedics Group
$20.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$20.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.15 (0.74%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell TMDX and other stocks, options, ETFs, and crypto commission-free!
About TMDX
TransMedics Group, Inc. Common Stock, also called TransMedics Group, is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. Read More It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.
Employees
94
Headquarters
Andover, Massachusetts
Founded
2018
Market Cap
432.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
107.12K
High Today
$20.80
Low Today
$20.00
Open Price
$20.44
Volume
83.04K
52 Week High
$31.54
52 Week Low
$16.00
Collections
Technology
New On Robinhood
Health
Medical
2019 IPO
US
North America
TMDX Earnings
-$4.86
-$3.37
-$1.89
-$0.40
Q1 2019
Q2 2019
Estimated
-$0.40 per share
Actual
-$0.44 per share